Skip to main content
SpringerLink
Log in

Surgical Margins in Breast-Conserving Surgery

  • Chapter
  • First Online:
Oncoplastic and Reconstructive Breast Surgery

  • 1427 Accesses

Abstract

The understanding of margins has changed with awareness that factors in addition to tumor burden such as tumor biology and the effectiveness of systemic therapy impact local control in invasive cancer. This chapter reviews pathologic techniques of margin assessment and what is known about the relationship between margin width and local control for invasive carcinoma and intraductal carcinoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347(8):567–575

    Article  PubMed  Google Scholar 

  2. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232

    Article  PubMed  Google Scholar 

  3. Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, Geyer CE Jr, Wickerham DL, Costantino JP, Wolmark N (2009) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol 27(15):2466–2473

    Article  PubMed  PubMed Central  Google Scholar 

  4. Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE Jr, Jeong JH, Tan-Chiu E, Fisher B, Wolmark N (2006) Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 24(13):2028–2037

    Article  PubMed  Google Scholar 

  5. Morrow M, Jagsi R, Alderman AK, Griggs JJ, Hawley ST, Hamilton AS, Graff JJ, Katz SJ (2009) Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 302(14):1551–1556

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, Godwin J, Gray R, Hicks C, James S, MacKinnon E, McGale P, McHugh T, Peto R, Taylor C, Wang Y (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106

    Article  CAS  PubMed  Google Scholar 

  7. Apple SK (2006) Variability in gross and microscopic pathology reporting in excisional biopsies of breast cancer tissue. Breast J 12(2):145–149

    Article  PubMed  Google Scholar 

  8. Molina MA, Snell S, Franceschi D, Jorda M, Gomez C, Moffat FL, Powell J, Avisar E (2009) Breast specimen orientation. Ann Surg Oncol 16(2):285–288

    Article  CAS  PubMed  Google Scholar 

  9. Carter D (1986) Margins of “lumpectomy” for breast cancer. Hum Pathol 17(4):330–332

    Article  CAS  PubMed  Google Scholar 

  10. Guidi AJ, Connolly JL, Harris JR, Schnitt SJ (1997) The relationship between shaved margin and inked margin status in breast excision specimens. Cancer 79(8):1568–1573

    Article  CAS  PubMed  Google Scholar 

  11. Wright MJ, Park J, Fey JV, Park A, O’Neill A, Tan LK, Borgen PI, Cody HS 3rd, Van Zee KJ, King TA (2007) Perpendicular inked versus tangential shaved margins in breast-conserving surgery: does the method matter? J Am Coll Surg 204(4):541–549

    Article  PubMed  Google Scholar 

  12. Cao D, Lin C, Woo SH, Vang R, Tsangaris TN, Argani P (2005) Separate cavity margin sampling at the time of initial breast lumpectomy significantly reduces the need for reexcisions. Am J Surg Pathol 29(12):1625–1632

    Article  PubMed  Google Scholar 

  13. Huston TL, Pigalarga R, Osborne MP, Tousimis E (2006) The influence of additional surgical margins on the total specimen volume excised and the reoperative rate after breast-conserving surgery. Am J Surg 192(4):509–512

    Article  PubMed  Google Scholar 

  14. Jacobson AF, Asad J, Boolbol SK, Osborne MP, Boachie-Adjei K, Feldman SM (2008) Do additional shaved margins at the time of lumpectomy eliminate the need for re-excision? Am J Surg 196(4):556–558

    Article  PubMed  Google Scholar 

  15. Kobbermann A, Unzeitig A, Xie XJ, Yan J, Euhus D, Peng Y, Sarode V, Moldrem A, Marilyn Leitch A, Andrews V, Stallings C, Rao R (2011) Impact of routine cavity shave margins on breast cancer re-excision rates. Ann Surg Oncol 18(5):1349–1355

    Article  PubMed  Google Scholar 

  16. Marudanayagam R, Singhal R, Tanchel B, O’Connor B, Balasubramanian B, Paterson I (2008) Effect of cavity shaving on reoperation rate following breast-conserving surgery. Breast J 14(6):570–573

    Article  PubMed  Google Scholar 

  17. Rizzo M, Iyengar R, Gabram SG, Park J, Birdsong G, Chandler KL, Mosunjac MB (2010) The effects of additional tumor cavity sampling at the time of breast-conserving surgery on final margin status, volume of resection, and pathologist workload. Ann Surg Oncol 17(1):228–234

    Article  PubMed  Google Scholar 

  18. Tengher-Barna I, Hequet D, Reboul-Marty J, Frassati-Biaggi A, Seince N, Rodrigues-Faure A, Uzan M, Ziol M (2009) Prevalence and predictive factors for the detection of carcinoma in cavity margin performed at the time of breast lumpectomy. Mod Pathol 22(2):299–305

    Article  PubMed  Google Scholar 

  19. Chagpar AB, Killelea BK, Tsangaris TN, Butler M, Stavris K, Li F, Yao X, Bossuyt V, Harigopal M, Lannin DR, Pusztai L, Horowitz NR (2015) A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med 373(6):503–510

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Moo TA, Choi L, Culpepper C, Olcese C, Heerdt A, Sclafani L, King TA, Reiner AS, Patil S, Brogi E, Morrow M, Van Zee KJ (2014) Impact of margin assessment method on positive margin rate and total volume excised. Ann Surg Oncol 21(1):86–92

    Article  PubMed  Google Scholar 

  21. Graham RA, Homer MJ, Katz J, Rothschild J, Safaii H, Supran S (2002) The pancake phenomenon contributes to the inaccuracy of margin assessment in patients with breast cancer. Am J Surg 184(2):89–93

    Article  PubMed  Google Scholar 

  22. Schnabel F, Boolbol SK, Gittleman M, Karni T, Tafra L, Feldman S, Police A, Friedman NB, Karlan S, Holmes D, Willey SC, Carmon M, Fernandez K, Akbari S, Harness J, Guerra L, Frazier T, Lane K, Simmons R, Estabrook A, Allweiss T (2014) A randomized prospective study of lumpectomy margin assessment with use of marginprobe in patients with nonpalpable breast malignancies. Ann Surg Oncol 21(5):6

    Article  Google Scholar 

  23. Sebastian M, Akbari S, Anglin B, Lin EH, Police AM (2015) The impact of use of an intraoperative margin assessment device on re-excision rates. Springerplus 4:198

    Article  PubMed  PubMed Central  Google Scholar 

  24. Zysk AM, Chen K, Gabrielson E, Tafra L, May Gonzalez EA, Canner JK, Schneider EB, Cittadine AJ, Scott Carney P, Boppart SA, Tsuchiya K, Sawyer K, Jacobs LK (2015) Intraoperative assessment of final margins with a handheld optical imaging probe during breast-conserving surgery may reduce the reoperation rate: results of a multicenter study. Ann Surg Oncol 22(10):3356–3362

    Article  PubMed  PubMed Central  Google Scholar 

  25. Azu M, Abrahamse P, Katz SJ, Jagsi R, Morrow M (2010) What is an adequate margin for breast-conserving surgery? Surgeon attitudes and correlates. Ann Surg Oncol 17(2):558–563

    Article  PubMed  Google Scholar 

  26. Taghian A, Mohiuddin M, Jagsi R, Goldberg S, Ceilley E, Powell S (2005) Current perceptions regarding surgical margin status after breast-conserving therapy: results of a survey. Ann Surg 241(4):629–639

    Article  PubMed  PubMed Central  Google Scholar 

  27. Waljee JF, Hu ES, Newman LA, Alderman AK (2008) Predictors of re-excision among women undergoing breast-conserving surgery for cancer. Ann Surg Oncol 15(5):1297–1303

    Article  PubMed  Google Scholar 

  28. Kurniawan ED, Wong MH, Windle I, Rose A, Mou A, Buchanan M, Collins JP, Miller JA, Gruen RL, Mann GB (2008) Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Ann Surg Oncol 15(9):2542–2549

    Article  PubMed  Google Scholar 

  29. Lovrics PJ, Cornacchi SD, Farrokhyar F, Garnett A, Chen V, Franic S, Simunovic M (2010) Technical factors, surgeon case volume and positive margin rates after breast conservation surgery for early-stage breast cancer. Can J Surg 53(5):305–312

    PubMed  PubMed Central  Google Scholar 

  30. Arriagada R, Le MG, Rochard F, Contesso G (1996) Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group. J Clin Oncol 14(5):1558–1564

    Article  CAS  PubMed  Google Scholar 

  31. Blichert-Toft M, Rose C, Andersen JA, Overgaard M, Axelsson CK, Andersen KW, Mouridsen HT (1992) Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group. J Natl Cancer Inst Monogr (11):19–25

    Google Scholar 

  32. Poggi MM, Danforth DN, Sciuto LC, Smith SL, Steinberg SM, Liewehr DJ, Menard C, Lippman ME, Lichter AS, Altemus RM (2003) Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 98(4):697–702

    Article  PubMed  Google Scholar 

  33. van Dongen JA, Voogd AC, Fentiman IS, Legrand C, Sylvester RJ, Tong D, van der Schueren E, Helle PA, van Zijl K, Bartelink H (2000) Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92(14):1143–1150

    Article  PubMed  Google Scholar 

  34. Veronesi U, Volterrani F, Luini A, Saccozzi R, Del Vecchio M, Zucali R, Galimberti V, Rasponi A, Di Re E, Squicciarini P et al (1990) Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26(6):671–673

    Article  CAS  PubMed  Google Scholar 

  35. Houssami N, Macaskill P, Luke Marinovich M, Morrow M (2014) The association of surgical margins and local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol 21(3):717–730

    Article  PubMed  PubMed Central  Google Scholar 

  36. Dillon DA, Guidi AJ, Schnitt SJ (2010) Pathology of invasive breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborne CK (eds) Diseases of the breast, 4th edn. Wolters Kluwer, Philadelphia, pp 374–407

    Google Scholar 

  37. Molland JG, Donnellan M, Janu NC, Carmalt HL, Kennedy CW, Gillett DJ (2004) Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma. Breast 13(5):389–396

    Article  CAS  PubMed  Google Scholar 

  38. Peiro G, Bornstein BA, Connolly JL, Gelman R, Hetelekidis S, Nixon AJ, Recht A, Silver B, Harris JR, Schnitt SJ (2000) The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 59(1):49–54

    Article  CAS  PubMed  Google Scholar 

  39. Santiago RJ, Harris EE, Qin L, Hwang WT, Solin LJ (2005) Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: the University of Pennsylvania experience. Cancer 103(12):2447–2454

    Article  PubMed  Google Scholar 

  40. Galimberti V, Maisonneuve P, Rotmensz N, Viale G, Sangalli C, Sargenti M, Brenelli F, Gentilini O, Intra M, Bassi F, Luini A, Zurrida S, Veronesi P, Colleoni M, Veronesi U (2011) Influence of margin status on outcomes in lobular carcinoma: experience of the European Institute of Oncology. Ann Surg 253(3):580–584

    Article  PubMed  Google Scholar 

  41. Harris JR (1996) Breast-conserving therapy as a model for creating new knowledge in clinical oncology. Int J Radiat Oncol Biol Phys 35(4):641–648

    Article  CAS  PubMed  Google Scholar 

  42. Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JH, Verbeek AL, Schnitt SJ, Silver B, Boyages J, Harris JR (1990) The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8(1):113–118

    Article  CAS  PubMed  Google Scholar 

  43. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, Collette L, Pierart M (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345(19):1378–1387

    Article  CAS  PubMed  Google Scholar 

  44. Park CC, Mitsumori M, Nixon A, Recht A, Connolly J, Gelman R, Silver B, Hetelekidis S, Abner A, Harris JR, Schnitt SJ (2000) Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18(8):1668–1675

    Article  CAS  PubMed  Google Scholar 

  45. Faverly DR, Burgers L, Bult P, Holland R (1994) Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 11(3):193–198

    CAS  PubMed  Google Scholar 

  46. Darvishian F, Hajdu SI, DeRisi DC (2003) Significance of linear extent of breast carcinoma at surgical margin. Ann Surg Oncol 10(1):48–51

    Article  PubMed  Google Scholar 

  47. Holland R, Veling SH, Mravunac M, Hendriks JH (1985) Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 56(5):979–990

    Article  CAS  PubMed  Google Scholar 

  48. Bartelink H, Horiot JC, Poortmans PM, Struikmans H, Van den Bogaert W, Fourquet A, Jager JJ, Hoogenraad WJ, Oei SB, Warlam-Rodenhuis CC, Pierart M, Collette L (2007) Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25(22):3259–3265

    Article  PubMed  Google Scholar 

  49. Fisher B, Dignam J, Bryant J, DeCillis A, Wickerham DL, Wolmark N, Costantino J, Redmond C, Fisher ER, Bowman DM, Deschenes L, Dimitrov NV, Margolese RG, Robidoux A, Shibata H, Terz J, Paterson AH, Feldman MI, Farrar W, Evans J, Lickley HL (1996) Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst 88(21):1529–1542

    Article  CAS  PubMed  Google Scholar 

  50. Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N (2005) Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353(16):1673–1684

    Article  CAS  PubMed  Google Scholar 

  51. Mamounas EP, Tang G, Fisher B, Paik S, Shak S, Costantino JP, Watson D, Geyer CE Jr, Wickerham DL, Wolmark N (2010) Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor-positive breast cancer: results from NSABP B-14 and NSABP B-20. J Clin Oncol 28(10):1677–1683

    Article  PubMed  PubMed Central  Google Scholar 

  52. Millar EK, Graham PH, O’Toole SA, McNeil CM, Browne L, Morey AL, Eggleton S, Beretov J, Theocharous C, Capp A, Nasser E, Kearsley JH, Delaney G, Papadatos G, Fox C, Sutherland RL (2009) Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol 27(28):4701–4708

    Article  PubMed  Google Scholar 

  53. Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26(14):2373–2378

    Article  PubMed  Google Scholar 

  54. Kyndi M, Sorensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J (2008) Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol 26(9):1419–1426

    Article  CAS  PubMed  Google Scholar 

  55. Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ (2012) Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat 133(3):831–841

    Article  PubMed  Google Scholar 

  56. Kiess AP, McArthur HL, Mahoney K, Patil S, Morris PG, Ho A, Hudis CA, McCormick B (2012) Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2-positive breast cancer. Cancer 118(8):1982–1988

    Article  CAS  PubMed  Google Scholar 

  57. Pilewskie M, Ho A, Orell E, Stempel M, Chen Y, Eaton A, Patil S, Morrow M (2014) Effect of margin width on local recurrence in triple-negative breast cancer patients treated with breast-conserving therapy. Ann Surg Oncol 21(4):1209–1214

    Article  PubMed  Google Scholar 

  58. Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, Cruz AB Jr, Fisher ER, Wickerham DL, Wolmark N, DeCillis A, Hoehn JL, Lees AW, Dimitrov NV (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15(7):2483–2493

    Article  CAS  PubMed  Google Scholar 

  59. van der Hage JA, van de Velde CJ, Julien JP, Tubiana-Hulin M, Vandervelden C, Duchateau L (2001) Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 19(22):4224–4237

    Article  PubMed  Google Scholar 

  60. Mieog JS, van der Hage JA, van de Velde CJ (2007) Preoperative chemotherapy for women with operable breast cancer. Cochrane Database Syst Rev (2):CD005002

    Google Scholar 

  61. Wolmark N, Wang J, Mamounas E, Bryant J, Fisher B (2001) Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr (30):96–102

    Google Scholar 

  62. Hylton N (2006) MR imaging for assessment of breast cancer response to neoadjuvant chemotherapy. Magn Reson Imaging Clin N Am 14(3):383–389 vii

    Article  PubMed  Google Scholar 

  63. Jochelson MS, Lampen-Sachar K, Gibbons G, Dang C, Lake D, Morris EA, Morrow M (2015) Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy? Ann Surg Oncol 22(5):1490–1495

    Article  PubMed  PubMed Central  Google Scholar 

  64. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Schechter NR, Hortobagyi GN, Buchholz TA (2004) Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 22(12):2303–2312

    Article  PubMed  Google Scholar 

  65. Meyers MO, Klauber-Demore N, Ollila DW, Amos KD, Moore DT, Drobish AA, Burrows EM, Dees EC, Carey LA (2011) Impact of breast cancer molecular subtypes on locoregional recurrence in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. Ann Surg Oncol 18(10):2851–2857

    Article  PubMed  Google Scholar 

  66. Ataseven B, Lederer B, Blohmer JU, Denkert C, Gerber B, Heil J, Kühn T, Kümmel S, Rezai M, Loibl S, von Minckwitz G (2015) Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy. Ann Surg Oncol 22(4):1118–1127

    Article  PubMed  Google Scholar 

  67. Morrow M, Harris JR (2007) Practice guideline for breast conservation therapy in the management of invasive breast cancer. J Am Coll Surg 205:362–376

    Article  Google Scholar 

  68. Moran MS, Schnitt SJ, Guiliano AE, Harris JR, Khan SA, Horton J, Klimberg S, Chavez-MacGregor M, Freedman G, Houssami N, Johnson PL, Morrow M (2014) Society of Surgical Oncology - American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. J Clin Oncol 32(14):8

    Article  Google Scholar 

  69. Cuzick J, Sestak I, Pinder SE, Ellis IO, Forsyth S, Bundred NJ, Forbes JF, Bishop H, Fentiman IS, George WD (2011) Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 12(1):21–29

    Article  CAS  PubMed  Google Scholar 

  70. Emdin S, Granstrand B, Ringberg A, Sandelin K, Arnesson LG, Nordgren H, Anderson H, Garmo H, Holmberg L, Wallgren A (2006a) SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol 45(5):536–543

    Article  PubMed  Google Scholar 

  71. Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, Land SR, Margolese RG, Swain SM, Costantino JP, Wolmark N (2011) Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 103(6):478–488

    Article  PubMed  PubMed Central  Google Scholar 

  72. Dunne C, Burke JP, Morrow M, Kell MR (2009) Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27(10):1615–1620

    Article  PubMed  Google Scholar 

  73. Dick AW, Sorbero MS, Ahrendt GM, Hayman JA, Gold HT, Schiffhauer L, Stark A, Griggs JJ (2011) Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons. J Natl Cancer Inst 103(2):92–104

    Article  PubMed  PubMed Central  Google Scholar 

  74. van Zee KJ, Subhedar P, Olcese C, Patil S, Morrow M (2015) The relationship between margin width and recurrence of ductal carcinoma in situ: analysis of 2996 women treated with breast-conserving surgery over 30 years. Ann Surg 262(4):623–631

    Article  PubMed  Google Scholar 

  75. Aref A, Youssef E, Washington T, Segel M, Grigorian C, Bongers S, Bouwman D (2000) The value of postlumpectomy mammogram in the management of breast cancer patients presenting with suspicious microcalcifications. Cancer J Sci Am 6(1):25–27

    CAS  PubMed  Google Scholar 

  76. Gluck BS, Dershaw DD, Liberman L, Deutch BM (1993) Microcalcifications on postoperative mammograms as an indicator of adequacy of tumor excision. Radiology 188(2):469–472

    Article  CAS  PubMed  Google Scholar 

  77. Silverstein MJ, Lagios MD, Groshen S, Waisman JR, Lewinsky BS, Martino S, Gamagami P, Colburn WJ (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340(19):1455–1461

    Article  CAS  PubMed  Google Scholar 

  78. Hughes LL, Wang M, Page DL, Gray R, Solin LJ, Davidson NE, Lowen MA, Ingle JN, Recht A, Wood WC (2009) Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27(32):5319–5324

    Article  PubMed  PubMed Central  Google Scholar 

  79. Morrow M, Van Zee KJ, Solin LJ, Houssami N, Chavez-MacGregor M, Harris JR, Horton J, Hwang S, Johnson PL, Marinovich ML, Schnitt SJ, Wapnir I, Moran MS (2016) Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Ann Surg Oncol 23(12):3801–3810

    Article  PubMed  PubMed Central  Google Scholar 

  80. Marinovich ML, Azizi L, Macaskill P, Irwig L, Morrow M, Solin LJ, Houssami N (2016) The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol 23(12):3811–3821

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Anita Mamtani & Monica Morrow

  2. Department of Pathology, Mount Sinai Health System, New York, NY, USA

    Adriana D. Corben

Authors
  1. Anita Mamtani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adriana D. Corben
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Monica Morrow
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Monica Morrow .

Editor information

Editors and Affiliations

  1. Our Lady of Grace Hospital, Positivo University, Curitiba, Brazil

    Cicero Urban

  2. Plastic and Reconstructive Division, European Institute of Oncology, Milan, Italy

    Mario Rietjens

  3. Memorial Sloan Kettering Cancer Center, New York, USA

    Mahmoud El-Tamer

  4. Memorial Sloan Kettering Cancer Center, New York, USA

    Virgilio S. Sacchini

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mamtani, A., Corben, A.D., Morrow, M. (2019). Surgical Margins in Breast-Conserving Surgery. In: Urban, C., Rietjens, M., El-Tamer, M., Sacchini, V.S. (eds) Oncoplastic and Reconstructive Breast Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-62927-8_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-62927-8_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-62925-4

  • Online ISBN: 978-3-319-62927-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation